Robert E. Landry joined Regeneron in 2013 as Senior Vice President, Finance and Chief Financial Officer. Previously, Mr. Landry served as Senior Vice President and Treasurer of Pfizer, Inc. Prior to serving as Senior Vice President and Treasurer of Pfizer, Mr. Landry held a variety of U.S. and international financial and general management positions at Wyeth Pharmaceuticals and Pfizer including Senior Vice President — Finance, Pfizer’s Diversified Businesses, Treasurer of Wyeth, Director of Sales and Marketing and Chief Financial Officer for Wyeth’s Australian and New Zealand affiliates, and various other assignments in both the pharmaceuticals business and the parent company. Mr. Landry joined Wyeth after spending two years as an auditor with PricewaterhouseCoopers LLP. He holds a B.B.A in Accounting from the University of Notre Dame.

Robert E. Landry joined Regeneron in 2013 as Senior Vice President, Finance and Chief Financial Officer. Previously, Mr. Landry served as Senior Vice President and Treasurer of Pfizer, Inc. Prior to serving as Senior Vice President and Treasurer of Pfizer, Mr. Landry held a variety of U.S. and international financial and general management positions at Wyeth Pharmaceuticals and Pfizer including Senior Vice President — Finance, Pfizer’s Diversified Businesses, Treasurer of Wyeth, Director of Sales and Marketing and Chief Financial Officer for Wyeth’s Australian and New Zealand affiliates, and various other assignments in both the pharmaceuticals business and the parent company. Mr. Landry joined Wyeth after spending two years as an auditor with PricewaterhouseCoopers LLP. He holds a B.B.A in Accounting from the University of Notre Dame.